Clinical Trial Update: A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase I/II study evaluating interferon alfa-5 in treatment-experienced patients with genotype 1 chronic hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon alfa-5 (interferon alfa-5)

Snippet

Sponsor: Digna Biotech S.L. | Conditions: Chronic Hepatitis C Virus Infection, Genotype 1 | Phase 1, Phase 2 | Status: COMPLETED